Excess Coronary Artery Disease Risk in South Asian Immigrants: Can Dysfunctional High-density Lipoprotein Explain Increased Risk?

Overview

Journal Vasc Health Risk Manag

Publisher Dove Medical Press

Specialty Cardiology & Vascular Diseases

Date 2009 Feb 3

PMID 19183743

Citations 22

Authors

Sunita Dodani

Affiliations

Soon will be listed here.

Abstract

Background: Coronary artery disease (CAD) is the leading cause of mortality and morbidity in the United States (US), and South Asian immigrants (SAIs) have a higher risk of CAD compared to Caucasians. Traditional risk factors may not completely explain high risk, and some of the unknown risk factors need to be explored. This short review is mainly focused on the possible role of dysfunctional high-density lipoprotein (HDL) in causing CAD and presents an overview of available literature on dysfunctional HDL.

Discussion: The conventional risk factors, insulin resistance parameters, and metabolic syndrome, although important in predicting CAD risk, may not sufficiently predict risk in SAIs. HDL has antioxidant, antiinflammatory, and antithrombotic properties that contribute to its function as an antiatherogenic agent. Recent Caucasian studies have shown HDL is not only ineffective as an antioxidant but, paradoxically, appears to be prooxidant, and has been found to be associated with CAD. Several causes have been hypothesized for HDL to become dysfunctional, including Apo lipoprotein A-I (Apo A-I) polymorphisms. New risk factors and markers like dysfunctional HDL and genetic polymorphisms may be associated with CAD.

Conclusions: More research is required in SAIs to explore associations with CAD and to enhance early detection and prevention of CAD in this high risk group.

Citing Articles

Control of cardiometabolic risk factors and their association with carotid intima media thickness among patients with type 2 diabetes mellitus-single center experience in a developing country.

Weerarathna T, Lekamwasam S, Kodikara I, Wasana K, Fonseka L Turk J Med Sci. 2024; 54(3):545-554.

PMID: 39050007 PMC: 11265882. DOI: 10.55730/1300-0144.5821.

The impact of the Sri Lankan economic crisis on medication adherence: An online cross-sectional survey.

Jayawardena R, Kodithuwakku W, Sooriyaarachchi P Dialogues Health. 2024; 2:100137.

PMID: 38515479 PMC: 10953977. DOI: 10.1016/j.dialog.2023.100137.

Cardiovascular Disease in South Asian Immigrants: a Review of Dysfunctional HDL as a Potential Marker.

Dod R, Rajendran A, Kathrotia M, Clarke A, Dodani S J Racial Ethn Health Disparities. 2022; 10(3):1194-1200.

PMID: 35449485 PMC: 9022895. DOI: 10.1007/s40615-022-01306-6.

Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies.

Anoop S S, DasGupta R, Rebekah G, Jose A, Inbakumari M, Finney G BMJ Open Diabetes Res Care. 2021; 9(1).

PMID: 34531243 PMC: 8449941. DOI: 10.1136/bmjdrc-2021-002414.

Lipids in South Asians: Epidemiology and Management.

Makshood M, Post W, Kanaya A Curr Cardiovasc Risk Rep. 2021; 13(8).

PMID: 33833849 PMC: 8026164. DOI: 10.1007/s12170-019-0618-9.

References

Mohan V, Deepa R, Rani S, Premalatha G . Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol. 2001; 38(3):682-7. DOI: 10.1016/s0735-1097(01)01415-2. View

Barter P, Baker P, Rye K . Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Curr Opin Lipidol. 2002; 13(3):285-8. DOI: 10.1097/00041433-200206000-00008. View

DAgostino Sr R, Grundy S, Sullivan L, Wilson P . Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001; 286(2):180-7. DOI: 10.1001/jama.286.2.180. View

Enas E . Coronary artery disease epidemic in Indians: a cause for alarm and call for action. J Indian Med Assoc. 2001; 98(11):694-5, 697-702. View

Anand S, Yusuf S, Vuksan V, Devanesen S, Teo K, Montague P . Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000; 356(9226):279-84. DOI: 10.1016/s0140-6736(00)02502-2. View

Ansell B, Fonarow G, Navab M, Fogelman A . Modifying the anti-inflammatory effects of high-density lipoprotein. Curr Atheroscler Rep. 2006; 9(1):57-63. DOI: 10.1007/BF02693941. View

Boekholdt S, Souverein O, Tanck M, Hovingh G, Kuivenhoven J, Peters R . Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels. Clin Genet. 2006; 69(3):263-70. DOI: 10.1111/j.1399-0004.2006.00578.x. View

Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G . Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health (Oxf). 2005; 27(1):93-100. DOI: 10.1093/pubmed/fdh202. View

Yancey P, Bortnick A, Kellner-Weibel G, de la Llera-Moya M, Phillips M, Rothblat G . Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol. 2003; 23(5):712-9. DOI: 10.1161/01.ATV.0000057572.97137.DD. View

10.

Fogelman A . When good cholesterol goes bad. Nat Med. 2004; 10(9):902-3. DOI: 10.1038/nm0904-902. View

11.

Gordon D, Probstfield J, Garrison R, Neaton J, CASTELLI W, Knoke J . High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989; 79(1):8-15. DOI: 10.1161/01.cir.79.1.8. View

12.

Goyal A, Yusuf S . The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res. 2006; 124(3):235-44. View

13.

Kumar A, Reynolds W . Statins downregulate myeloperoxidase gene expression in macrophages. Biochem Biophys Res Commun. 2005; 331(2):442-51. DOI: 10.1016/j.bbrc.2005.03.204. View

14.

Remaley A, Stonik J, Demosky S, Neufeld E, Bocharov A, Vishnyakova T . Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun. 2001; 280(3):818-23. DOI: 10.1006/bbrc.2000.4219. View

15.

Islam M, Raitakari O, Juonala M, Kahonen M, Hutri-Kahonen N, Collings A . Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms and their association with carotid artery intima-media thickness in the Finnish population. The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2005; 180(1):79-86. DOI: 10.1016/j.atherosclerosis.2004.10.043. View

16.

Luepker R, Arnett D, Jacobs Jr D, Duval S, Folsom A, Armstrong C . Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey. Am J Med. 2006; 119(1):42-9. DOI: 10.1016/j.amjmed.2005.08.051. View

17.

Kottke T, Thomas R, Lopez-Jimenez F, Brekke L, Brekke M, Aase L . CardioVision 2020: program acceptance and progress after 4 years. Am J Prev Med. 2006; 30(2):137-43. DOI: 10.1016/j.amepre.2005.10.017. View

18.

Dodani S, Dong Y, Zhu H, George V . Can novel Apo A-I polymorphisms be responsible for low HDL in South Asian immigrants?. Indian J Hum Genet. 2010; 14(1):9-15. PMC: 2840779. DOI: 10.4103/0971-6866.42321. View

19.

Bedi U, Singh S, Syed A, Aryafar H, Arora R . Coronary artery disease in South Asians: an emerging risk group. Cardiol Rev. 2006; 14(2):74-80. DOI: 10.1097/01.crd.0000182411.88146.72. View

20.

Karathanasis S . Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci U S A. 1985; 82(19):6374-8. PMC: 390718. DOI: 10.1073/pnas.82.19.6374. View